Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name BI 836880
Trade Name
Synonyms BI836880|BI-836880|Bi-specific Anti-VEGF/Ang2 Nanobody BI 836880
Drug Descriptions

BI 836880 is a nanobody that binds to both VEGF and ANGPT2, which inhibits downstream signaling, potentially resulting in antitumor activity (PMID: 37140602).

DrugClasses VEGF Antibody 11
CAS Registry Number 2254603-60-4
NCIT ID C126644


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
BI 836880 BI 836880 0 0
BI 836880 + Effi-DEM + Ezabenlimab BI 836880 Effi-DEM Ezabenlimab 0 1
BI 836880 + Ezabenlimab BI 836880 Ezabenlimab 0 1

Additional content available in CKB BOOST